BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 8294062)

  • 1. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 4. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease and acute leukemia. Is it a true association?
    Avilés A; Díaz-Maqueo JC; Ayala JR; Cortés HD; García EL
    Arch Med Res; 1992; 23(1):65-8. PubMed ID: 1308794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Longo DL; DeVita VT
    Important Adv Oncol; 1992; ():155-65. PubMed ID: 1582671
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
    Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M; Pianezze G; Fabris P; Cemin S; Coser P
    Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
    [No Abstract]   [Full Text] [Related]  

  • 12. [Second tumors in patients treated for Hodgkin's disease].
    España P; Bonilla F; Yebra M; Diego J; Alvarez de Mon M; Marazuela M; Durántez A
    Rev Clin Esp; 1988 Apr; 182(6):304-6. PubMed ID: 3406475
    [No Abstract]   [Full Text] [Related]  

  • 13. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
    Jenkin D; Doyle J
    Cancer Treat Res; 1989; 41():247-56. PubMed ID: 2577078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.